Financings in Brief: EndoSonics
This article was originally published in The Gray Sheet
Executive Summary
EndoSonics: Pleasanton, California-based catheter and intravascular imaging system manufacturer files registration statement with the Securities and Exchange Commission for a secondary offering of 2.3 mil. shares of common stock. Stock in EndoSonics closed at 13-1/2 on Oct. 13, the day the offering was announced. Piper Jaffray and Volpe, Welty & Co. are lead underwriters, EndoSonics says, noting that underwriters have an overallotment option to buy 345,000 additional shares...
You may also be interested in...
Vaccine Distribution Priorities To Rely On Governors, Not ACIP, HHS Secretary Azar Says
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi Grapples With Pandemic, Growing Clinical Trials, Implementing Acquisitions
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
ATAI Raises $125m Series C To Expand The Boundaries In Mental Health
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: